Mark J. Millan

26.5k citations

284 papers · 19.3k indexed · 5 hit papers · h-index 70

Impact in

Biological Psychiatry top 0.1%
- Tryptophan and brain disorders
Cellular and Molecular Neuroscience top 0.05%
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
- Neuropeptides and Animal Physiology

Papers in

Cellular and Molecular Neuroscience 214
- Neurotransmitter Receptor Influence on Behavior 127
- Neuroscience and Neuropharmacology Research 94
- Neuropeptides and Animal Physiology 49
Behavioral Neuroscience 24
- Stress Responses and Cortisol 24

Co-authors: Alain P. Gobert Adrian Newman‐Tancredi Anne Dekeyne Jean‐Michel Rivet Mauricette Brocco Didier Cussac Jeffrey N. Joyce Clotilde Mannoury la Cour
Journals: European Journal of Pharmacology (29 papers)European Neuropsychopharmacology (24 papers)Neuropharmacology (21 papers)Psychopharmacology (21 papers)Journal of Pharmacology and Experimental Therapeutics (12 papers)
Partner nations: France United States United Kingdom

In The Last Decade

Mark J. Millan

284 papers receiving 18.8k citations

Hit Papers

5 papers align trajectories log scale

Prevention of Psychosis 2020 · 294 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 JAMA Psychiatry
2018 Nature Reviews Drug Discovery
2003 Progress in Neurobiology
2002 Progress in Neurobiology
1999 Progress in Neurobiology

Peers

Countries citing papers authored by Mark J. Millan

Since Specialization

Citations

This map shows the geographic impact of Mark J. Millan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Millan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Millan more than expected).

Fields of papers citing papers by Mark J. Millan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Millan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Millan. The network helps show where Mark J. Millan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark J. Millan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark J. Millan Line = papers co-authored together Mark J. Millan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Orphan GPR50 Restrains Neurite Outgrowth and Cell Migration by Activating the G_12/13 Protein‐RhoA Pathway in Neural Progenitor Cells and Tanycytes Journal of Pineal Research ·Raise Ahmad, Marine Luka, سیدمصطفی جزایری شوشتری, Sarah Gallet, Alan Hégron, Marcio Do Cruzeiro, Mark J. Millan, Michala Kroniková, Bernard Masri, Julie Dam, Vincent Prévot, Ralf Jockers	2025	1
2	P62 accumulates through neuroanatomical circuits in response to tauopathy propagation Acta Neuropathologica Communications ·Ya Mei Guo, Benjamin Lassus, Майоров Евгений Евгеньевич, Stephanie L. Fowler, Chris N. Goulbourne, Ross Jeggo, Clotilde Mannoury la Cour, Mark J. Millan, Karen Duff	2021	18
3	Genetic deletion of GPR88 enhances the locomotor response to L-DOPA in experimental parkinsonism while counteracting the induction of dyskinesia Neuropharmacology ·Ioannis Mantas, A. CASTAÑEDA, Luan-ying Wu, Mark J. Millan, Xiaoqun Zhang, Per Svenningsson	2019	12
4	Glutamatergic and dopaminergic modulation of cortico-striatal circuits probed by dynamic calcium imaging of networks reconstructed in microfluidic chips Scientific Reports ·Benjamin Lassus, Jérémie Naudé, Philippe Fauré, Denis Guédin, Ysander von Boxberg, Clotilde Mannoury la Cour, Mark J. Millan, Jean‐Michel Peyrin	2018	21
5	Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling Molecular Psychiatry ·Laura Cavalleri, Emilio Merlo Pich, Mark J. Millan, Cristiano Chiamulera, Tilo Kunath, PierFranco Spano, Ginetta Collo	2017	111
6	Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer’s disease: An integrative review Progress in Neurobiology ·Mark J. Millan	2017	114
7	Quantification of extracellular levels of corticosterone in the basolateral amygdaloid complex of freely-moving rats: A dialysis study of circadian variation and stress-induced modulation Brain Research ·D Maistrou, Mark J. Millan, Jean‐Michel Rivet, Suryawanshi Suvarna, Rodrigo Albegaria Résio, Alain P. Gobert	2012	22
8	Agomelatine, the first melatonergic antidepressant: discovery, characterization and development Nature Reviews Drug Discovery ·Christian de Bodinat, Béatrice Guardiola‐Lemaître, Elisabeth Mocaër, Pierre Renard, Carmen Muñoz, Mark J. Millan	2010	342
9	Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: A comparative study of coupling to Gαs European Journal of Pharmacology ·Delphine S. Dupuis, Clotilde Mannoury la Cour, C. Chaput, Laurence Verrièle, Gilbert Lavielle, Mark J. Millan	2008	36
10	Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions Trends in Pharmacological Sciences ·Mark J. Millan, Philippe Marin, Jeanne Pagès, Luan-ying Wu	2008	232
11	Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease Neurobiology of Disease ·Naomi P. Visanji, Susan H. Fox, Tom H. Johnston, Gabriela Reyes, Mark J. Millan, Jonathan M. Brotchie	2008	79
12	Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity Proceedings of the National Academy of Sciences ·Benjamin Chanrion, Clotilde Mannoury la Cour, Federica Bertaso, Mireille Lerner‐Natoli, Michael Freissmuth, Mark J. Millan, Joël Bockaert, Philippe Marin	2007	141
13	Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors Psychopharmacology ·Mark J. Millan, Alonso Chumbipuma, Jean-Louis Péglion, Anne Dekeyne	2006	14
14	Dopamine D3 receptor agonists for protection and repair in Parkinson's disease Current Opinion in Pharmacology ·Jeffrey N. Joyce, Mark J. Millan	2006	91
15	Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of α₂‐adrenergic and serotonin_2C receptors: a comparison with citalopram European Journal of Neuroscience ·Mark J. Millan, Alain P. Gobert, Jean‐Michel Rivet, Prolin Tarigan, Didier Cussac, Adrian Newman‐Tancredi, Anne Dekeyne, Jean‐Paul Nicolas, F. Lejeune	2000	139
16	[3H](+)S 14297: A novel, selective radioligand at cloned human dopamine D3 receptors Neuropharmacology ·Adrian Newman‐Tancredi, Valérie Audinot, Vincent Jacques, J.‐L. PEGLION, Mark J. Millan	1995	9
17	Serotonin and pain: evidence that activation of 5-HT1A receptors does not elicit antinociception against noxious thermal, mechanical and chemical stimuli in mice Pain ·Mark J. Millan	1994	71
18	Competitive antagonism of serotonin (5-HT)2C and 5-HT2A receptormediated phosphoinositide (PI) turnover by clozapine in the rat: A comparison to other antipsychotics Neuroscience Letters ·Hervé Canton, Laurence Verrièle, Mark J. Millan	1994	36
19	Evidence that μ-opioid receptors mediate midbrain “stimulation-produced analgesia” in the freely moving rat Neuroscience ·Mark J. Millan, Johnson Kashi, A. Herz	1987	13
20	Spinal cord dynorphin may modulate nociception via a ℵ-opioid receptor in chronic arthritic rats Brain Research ·Mark J. Millan, (unknown), M.H. Millan, C.W.T. Pilcher, Karen E. Tracy, A. Herz, F. C. Colpaert	1985	61

About Mark J. Millan

Mark J. Millan is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience, Biological Psychiatry, Endocrine and Autonomic Systems and Molecular Biology, having authored 284 papers that have together received 19.3k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (128 papers), Neurotransmitter Receptor Influence on Behavior (127 papers), Neuroscience and Neuropharmacology Research (94 papers), Neuropeptides and Animal Physiology (49 papers), Pain Mechanisms and Treatments (36 papers), Neuroendocrine regulation and behavior (34 papers), Stress Responses and Cortisol (24 papers) and Treatment of Major Depression (23 papers). The work is most often cited by research in Biological Psychiatry (1.6k citations), Cellular and Molecular Neuroscience (10.4k citations), Behavioral Neuroscience (1.5k citations), Endocrine and Autonomic Systems (1.5k citations) and Physiology (5.0k citations). Mark J. Millan has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Alain P. Gobert, Adrian Newman‐Tancredi, Anne Dekeyne, Jean‐Michel Rivet, Mauricette Brocco, Didier Cussac, Jeffrey N. Joyce, Clotilde Mannoury la Cour, Valérie Pasteau and Franćoise Lejeune. Their work appears in journals such as European Journal of Pharmacology, European Neuropsychopharmacology, Neuropharmacology, Psychopharmacology and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact